by Asharq Al-Awsat English | Apr 28, 2016 | Health
A Bermuda-based company is closely studying an imminent ruling on Acadia Pharmaceuticals Inc’s drug for Parkinson’s disease psychosis, with a similar treatment for dementia. Axovant Sciences Ltd’s experimental drug for Lewy body dementia –...
